ST. LOUIS (MD Consult) - Pseudomonas aeruginosa expressing the recently discovered blaIMP gene produce IMP-1, a metallo-β-lactamase that is not inhibited by currently available β-lactams. The clinical characteristics of and risk factors for blaIMP-positive P aeruginosa are discussed in the July 1 issue of Clinical Infectious Diseases.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Infection
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
☆Summaries supplied courtesy of MD Consult Infectious Disease www.mdconsult.com
© 2003 Published by Elsevier Inc.